News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
FDA Panel Urges More Testing for Diabetes Drugs
July 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (Associated Press) - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Alzheimer’s disease
Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use
October 14, 2025
·
2 min read
·
Tristan Manalac
FDA
Consistency in the Chaos: FDA Approvals Within Average Range as Q4 Kicks Off
October 13, 2025
·
4 min read
·
Heather McKenzie
Rare Diseases
Ascendis Readies BioMarin Challenge in Achondroplasia While Others Search for Root Cause
October 13, 2025
·
7 min read
·
Tristan Manalac
Rare diseases
Nearly Three Quarters of FDA Breakthrough Designated Drugs Win Approval: Report
October 9, 2025
·
3 min read
·
Dan Samorodnitsky
